This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
06/02/15 - 3:51:45 PM ET (BATS BZX Real-time Price)
Div Yield: --
GALE Day's Range
GALE 52 Week Range
GALE Business Summary
Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs across cancer care.View GALE key stats
Galena Biopharma Inc - GALE - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Galena Biopharma Inc as a
Sell with a ratings score of D.
Report Snippet: We rate GALENA BIOPHARMA INC (GALE) a SELL. This is driven by a number of negative factors, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.